"Our clinic provides a wide range of specialized cardiovascular magnetic resonance (CMR) services, including magnetic resonance imaging, angiography, and stress testing for evaluating heart disease, vascular disease, and more."

During the past decade, Duke Cardiovascular Magnetic Resonance Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Duke Cardiovascular Magnetic Resonance Center" are "Atrial Septal Defect" (1 trials), "Coronary Arteriosclerosis" (1 trials), "Duchenne Muscular Dystrophy" (1 trials), "Hypertrophic Cardiomyopathy" (1 trials) and "Microvascular Ischaemia of Myocardium" (1 trials). Many other conditions were trialed in "Duke Cardiovascular Magnetic Resonance Center" in a lesser frequency.

Most popular intervention types in "Duke Cardiovascular Magnetic Resonance Center" are "Drug" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adenosine" (1 trials), "PF-06939926" (1 trials) and "Regadenoson" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke Cardiovascular Magnetic Resonance Center" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Duke Cardiovascular Magnetic Resonance Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Duke Cardiovascular Magnetic Resonance Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Duke Cardiovascular Magnetic Resonance Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".